
Pharmacally
Renal Cell Carcinoma
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Renal Cell Carcinoma
Clinical TrialsBelzutifan-Lenvatinib Improves Progression-Free Survival in Previously Treated Advanced Renal Cell CarcinomaThe phase 3 LITESPARK-011 trial showed that belzutifan plus lenvatinib significantly improved progression-free survival and objective response rates compared with cabozantinib in patients with advanced clear-cell renal cell…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.